📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
SRPL Submits Pending Annual Reports for FY24 & FY25; Requests Revocation of Trading Suspension
Shree Ram Proteins Limited (SRPL) has completed the submission of its Annual Reports for two consecutive financial years, FY 2023-24 and FY 2024-25, via the NEAPS portal on February 11, 2026. This action follows a suspension notice from the NSE dated December 30, 2025, triggered by non-compliance with Regulation 34 of SEBI (LODR) Regulations. The company is also filing a compounding petition under Section 441 of the Companies Act for delays in holding its Annual General Meetings. SRPL has formally requested the exchange to revoke the suspension of trading in its securities following these filings.
Key Highlights
Submitted pending Annual Reports for FY 2023-24 and FY 2024-25 on February 11, 2026
Addressed NSE suspension notice (Ref: NSE/LIST/C/2025/13391) regarding non-compliance
Initiated compounding petition under Section 441 for delays in holding AGMs for the specified years
Formally requested NSE to revoke the suspension of trading in the company's securities
💼 Action for Investors
Investors should wait for official confirmation from the NSE regarding the revocation of the trading suspension before making any decisions. The history of significant compliance delays and the need for legal compounding suggest a high-risk profile for this stock.
Shree Ram Proteins to Sell Land Undertaking for ₹30 Crore to Sova Agrotech
Shree Ram Proteins Limited (SRPL) has received shareholder approval to sell its land undertaking in Gondal, Rajkot, for a total consideration not exceeding ₹30 Crore. The sale is being made to Sova Agrotech Private Limited, a related party, with the transaction expected to be completed by April 2026. The company aims to use the proceeds to streamline its asset base, reduce maintenance costs, and focus on core business operations. The disposal was approved via a special resolution during the Extra Ordinary General Meeting held on March 5, 2026.
Key Highlights
Sale of land situated at Gondal, Rajkot for a consideration of up to ₹30 Crore.
Transaction is with Sova Agrotech Private Limited, a related party involving promoter Ms. Geetaben Lalitbhai Vasoya.
Expected completion date for the sale/disposal is set for April 2026.
Shareholder approval obtained via special resolution at the EGM held on March 5, 2026.
Strategic rationale includes streamlining assets and focusing on core business operations.
💼 Action for Investors
Investors should track the actual receipt of the ₹30 Crore and how the management redeploys this capital into core operations. Given it is a related party transaction, verify that the final valuation aligns with independent market benchmarks.
Shree Ram Proteins Shareholders Approve Asset Sale and QIP Capital Raise
Shree Ram Proteins Limited (SRPL) has received shareholder approval for two critical resolutions during its EOGM held on March 05, 2026. The first resolution, involving the sale of a company undertaking as a material related party transaction, passed with 100% of the 16,448,040 votes in favor. The second resolution authorizes the company to raise capital through a Qualified Institutions Placement (QIP), which was approved by a 99.91% majority. These approvals provide the company with the mandate to restructure its assets and seek fresh institutional investment.
Key Highlights
100% shareholder approval for the sale of a company undertaking as a material related party transaction involving 16,448,040 votes.
99.91% majority (16,436,640 votes) in favor of raising capital via Qualified Institutions Placement (QIP).
Total of 54 members participated in the electronic voting process representing 16,448,040 shares.
The QIP resolution saw minimal opposition, with only 15,000 votes (0.09%) cast against it.
💼 Action for Investors
Investors should monitor the pricing and dilution impact of the upcoming QIP and the specific terms of the asset sale. The high approval rate suggests strong alignment between participating shareholders and management's strategic restructuring plans.
Shree Ram Proteins Reports Zero Revenue and ₹21.07 Cr Net Loss in FY25; Issues AGM Addendum
Shree Ram Proteins Limited (SRPL) has issued a corrigendum and addendum to its 17th Annual Report and AGM notice, primarily to include the missing Secretarial Audit Report and correct director re-appointment details. The company's financial health has deteriorated severely, with revenue from operations falling to zero in FY 2024-25 compared to ₹1,476.60 Lakhs in the previous year. Net loss has more than doubled to ₹2,107.51 Lakhs, driven by the total halt in operations. The company is currently attempting to raise up to ₹49 Crores through a Rights Issue to stabilize its position.
Key Highlights
Revenue from operations dropped 100% to zero in FY 2024-25 from ₹1,476.60 Lakhs in FY 2023-24.
Net loss widened significantly to ₹2,107.51 Lakhs for the year ended March 31, 2025.
Corrigendum issued to correct the director retiring by rotation from Mr. Ravindra Kumar Singh to Mr. Piyush Vasoya.
Secretarial Audit Report for FY 2024-25 (pages 71-91) added as an addendum to the Annual Report.
Company is pursuing a Rights Issue of up to ₹49 Crores and a preferential allotment of 5 crore shares.
💼 Action for Investors
Investors should be highly concerned by the total cessation of operational revenue and the widening losses; the stock remains a high-risk speculative play contingent on the success of the proposed fundraise.
Shree Ram Proteins Reports Zero Revenue in FY25; Issues AGM Corrigendum for Director Re-appointment
Shree Ram Proteins Limited (SRPL) has issued a corrigendum to its 17th AGM notice, correcting the director retiring by rotation to Mr. Piyush Vasoya and adding the missing Secretarial Audit Report. The company's financial performance for FY 2024-25 reveals a total collapse in operations, with revenue from operations falling to zero from ₹1,476.60 Lakhs in the previous year. Consequently, the net loss widened significantly to ₹2,107.51 Lakhs compared to a loss of ₹958.48 Lakhs in FY 2023-24. The board has skipped dividends to conserve capital amid these severe operational challenges.
Key Highlights
Revenue from operations plummeted to zero in FY 2024-25 from ₹1,476.60 Lakhs in FY 2023-24.
Net loss for the year widened to ₹2,107.51 Lakhs, more than doubling from the previous year's loss of ₹958.48 Lakhs.
EBITDA stood at a negative ₹1,693.77 Lakhs, reflecting severe operational distress and lack of business activity.
The company corrected its AGM notice to reflect the re-appointment of Mr. Piyush Vasoya instead of Mr. Ravindra Kumar Singh.
The Secretarial Audit Report for FY 2024-25 was added as an addendum after being omitted from the initial report.
💼 Action for Investors
Investors should exercise extreme caution as the company has reported a total cessation of operational revenue and mounting losses. The lack of business activity suggests significant fundamental risks that require immediate clarification from management regarding the company's going concern status.
Shree Ram Proteins Reports Cessation of 3 Independent Directors Due to Delayed AGM
Shree Ram Proteins Limited (SRPL) has announced the cessation of three Additional Independent Directors effective February 5, 2026. The directors, Ms. Naaz Jaiswal, Mr. Akash Sureshbhai Gajera, and Mr. Yogeshbhaichandubhai Dhanani, have vacated their offices due to the company's failure to hold its Annual General Meeting (AGM) within the statutory due date. This automatic cessation is mandated under Section 161(1) of the Companies Act, 2013, which requires additional directors to step down on the date the AGM should have been held. This development highlights a significant lapse in corporate governance and regulatory compliance.
Key Highlights
Cessation of 3 Additional Independent Directors effective from February 5, 2026.
Directors involved are Ms. Naaz Jaiswal, Mr. Akash Sureshbhai Gajera, and Mr. Yogeshbhaichandubhai Dhanani.
The cessation resulted from the company's failure to conduct its Annual General Meeting (AGM) within the statutory timeline.
Action taken in accordance with Section 161(1) of the Companies Act, 2013.
The vacancy of three independent directors simultaneously may affect board composition and committee requirements.
💼 Action for Investors
Investors should exercise caution as the failure to hold an AGM on time is a red flag regarding internal controls and regulatory compliance. Monitor the company's next steps for appointing new directors and scheduling the overdue AGM.
SRPL to Raise ₹100 Cr and Acquire Stake in Sova Agrotech for ₹30 Cr
Shree Ram Proteins Limited (SRPL) has approved a major fundraising plan of up to ₹100 Crores through equity or convertible securities. A significant portion of these funds, up to ₹30 Crores, is designated for acquiring a controlling stake in Sova Agrotech Private Limited, which is currently settling debts with Union Bank. The company also approved the sale of its land in Rajkot and is undergoing a major board restructuring with four new director appointments. Notably, the company is clearing a backlog of compliance by scheduling its 15th and 16th AGMs simultaneously in March 2026.
Key Highlights
Approved fundraising of up to ₹100 Crores via preferential issue, rights issue, or other equity-linked instruments.
Proposed acquisition of a controlling stake in Sova Agrotech Private Limited for ₹30 Crores.
Sova Agrotech to acquire land, plant, and machinery for ₹24.75 Crores via a One Time Settlement (OTS) with Union Bank of India.
Approved the sale of company-owned land at Bhunava, Rajkot, subject to shareholder approval.
Scheduled the 15th AGM (FY24), 16th AGM (FY25), and an EGM all for March 5, 2026, to address pending regulatory matters.
💼 Action for Investors
Investors should be cautious as the company is holding AGMs for 2024 and 2025 in 2026, indicating significant past compliance delays. Monitor the specific terms of the ₹100 Crore fundraise and the valuation details of the Sova Agrotech acquisition before committing capital.